Overview
Updated 14 Jul 2026
Mark N. Stein, MD, is Associate Professor of Medicine (Medical Oncology) at Columbia University Irving Medical Center / Herbert Irving Comprehensive Cancer Center. The public record shows 507 publications with 11,950 citations (h-index 52), centered on Kidney Cancer / RCC, Lymphoma, Prostate Cancer. It also documents an investigator role on 30 registered clinical trials, industry payments reported by 13 companies.
- Most recent indexed publication: 2026 · Clinical cancer research
- Top research focus: Kidney Cancer / RCC
- 30 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 30 registered studies on ClinicalTrials.gov. The most recent:
- The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
InvestigatorPhase 3RecruitingNCT06520345 - ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
Sponsor: OncoC4, Inc.
InvestigatorPhase 1/PHASE2Active, not recruitingNCT05682443 - Efficacy of Trigeminal Nerve Stimulation for ADHD
Sponsor: University of California, Los Angeles
InvestigatorCompletedNCT05374187
Industry payments
Updated 14 Jul 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20253 payments
- Exelixis Inc.Program year202511 payments
- AstraZeneca UK LimitedProgram year20251 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
161 Fort Washington Avenue, New York, NY 10032
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- B.S.
Molecular Biophysics and Biochemistry, Yale University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - M.D.
New York Medical College
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - Internal Medicine Residency
Montefiore Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - Fellowship
Hematology and Medical Oncology, Mount Sinai Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - Board Certified
Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.columbia.edu ↗
Editorial & leadership rolesjournal and society appointments
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vagelos.columbia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.columbia.edu ↗
Awards & honorshonors on the public record
- Graduation Award in Oncology
New York Medical College (for published research)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
- Member
Experimental Therapeutics Program, Herbert Irving Comprehensive Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urotoday.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/mark-stein-md-81025a38
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Mark-Stein-13
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- X / Twitter
x.com/columbiacancer/status/1950651621869859248
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Rebecca Hahn, MD
Columbia University Medical Center
- 830
- publications
- 121
- h-index
- 3
- trials
Davangere Devanand, MD
Columbia University Medical Center
- 323
- publications
- 58
- h-index
- 10
- trials